Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–15 of 15 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT02133196
- Conditions
- Adenocarcinoma, Adenosquamous Carcinoma, Advanced NSCLC, +23 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06924606
- Conditions
- Advanced NSCLC
- Locations
-
- Beijing Chest Hospital, Capital Medical University Beijing, Beijing Municipality, China
- Jilin Cancer Hospital Jilin City, Changchun, China
- Hunan Cancer Hospital Hunan, Changsha, China
- West China Hospital, Sichuan University Sichuan, Chengdu, China
NCT06758557
- Conditions
- Advanced Endometrial Cancer, Advanced NSCLC, Endometrial Neoplasms, +11 more
- Locations
-
- Affiliated Hospital of Hebei University / School of Clinical Medicine Baoding, Hebei, China
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
- The First Affiliated Hospital of Henan University of Science & Technology Luoyang, Henan, China
- Henan Cancer Hospital Zhengzhou, Henan, China
NCT06752057
- Conditions
- Advanced NSCLC
- Locations
-
- First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
- The First Hospital of Nanchang Nanchang, Jiangxi, China
NCT06751849
- Conditions
- Advanced NSCLC
- Locations
-
- First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
- The First Hospital of Nanchang Nanchang, Jiangxi, China
NCT06751901
- Conditions
- Advanced NSCLC
- Locations
-
- First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
- The First Hospital of Nanchang Nanchang, Jiangxi, China
NCT06752044
- Conditions
- Advanced NSCLC
- Locations
-
- First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
- The First Hospital of Nanchang Nanchang, Jiangxi, China
Not Yet Recruiting
A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)
NCT05859217
- Conditions
- Advanced NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
- Locations
-
- The University of Kansas Cancer Center - Westwood Kansas City, Kansas, United States
- The University of Kansas Cancer Center - Indian Creek Overland Park, Kansas, United States
- The University of Kansas Cancer Center - North Kansas City, Missouri, United States
- The University of Kansas Cancer Center - Lee's Summit Lee's Summit, Missouri, United States
Not Yet Recruiting
A Single-arm Pilot Study of Tislelizumab Combined With Anlotinib in Patients With Advanced NSCLC With Driver-negative After Progression to Immunotherapy
NCT06356675
- Conditions
- Advanced NSCLC
- Locations
-
Not specified
NCT05219162
- Conditions
- Advanced NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
- Locations
-
- Research Site Beijing, China
- Research Site Changsha, China
- Research Site Chengdu, China
- Research Site Dalian, China
NCT03074175
- Conditions
- Advanced NSCLC
- Locations
-
- Xinqiao Hospital of Chongqing Chongqing, China
NCT03215810
- Conditions
- Adenocarcinoma, Adenocarcinomas, Adenosquamous Carcinoma, +25 more
- Locations
-
- University of Florida Health Cancer Center. Gainesville, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Completed
POSITIVE - Study (Part III) Heidelberg
NCT02055508
- Conditions
- Advanced NSCLC, Behavior, First Line Treatment, +8 more
- Locations
-
- Thoracic Oncology Clinic for Thoracic Diseases Heidelberg, Baden-Wurttemberg, Germany
Active, Not Recruiting
Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation
NCT05609578
- Conditions
- Advanced NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
- Locations
-
- Local Institution - 017-936C Fountain Valley, California, United States
- Local Institution - 017-936 Fountain Valley, California, United States
- Local Institution - 017-851 Fullerton, California, United States
- Local Institution - 017-540 San Francisco, California, United States
Active, Not Recruiting
Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC
NCT04043195
- Conditions
- Advanced NSCLC
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States